Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-15

Clinical Trial Update: Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs [NA]

View source ↗

Summary

A completed clinical trial assessing the effects of chromium, Phyllanthus emblica, and Shilajit on cardiovascular health, fitness, and weight loss during exerci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium (Chromium)
  • Phyllanthus emblica
  • Shilajit

Snippet

Sponsor: Kerry Group P.L.C | Conditions: Overweight, Metabolic Syndrome X | NA | Status: COMPLETED